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Abstract
Background Mal de Meleda (OMIM# 248300; keratosis palmoplantaris transgrediens) is
an autosomal recessive form of palmoplantar keratoderma, clinically characterized by
sharp demarcated erythema and hyperkeratosis of the palms and soles that progress with
age and extend to the dorsal aspects of the hands and feet. The mal de Meleda is caused
by mutations in the SLURP1 gene that encodes secreted lymphocyte antigen 6/urokinase-
type plasminogen receptor-related protein 1 (SLURP1). To date no reported cases from
Indonesia. The aims of the study were to describe the typical features of mal de Meleda
cases in a Javanese family in Indonesia and identify the mutation in the ARS B gene which
encodes SLURP1.
Patients and Methods In this study, three Javanese patients, siblings from
nonconsanguineous nonaffected parents, presented with classical symptoms of mal de
Meleda. Genetic analysis screening SLURP1 gene was conducted for the specimens from
the patients and other family members.
Results A novel homozygous three-nucleotide deletion in exon 3, i.e. c.271-273TCTdel,
was identified in the patients. Subcloning and sequencing revealed both parents (I.2 and
I.3) and one of the father’s siblings (I.1) carry heterozygous c.271-273TCTdel, while the
other father’s sibling (I.2), the mother’s sister (I.4), and a healthy control matched the
ethnicity of the family, showing normal sequence of the entire SLURP1.
Conclusion This is the first mal de Meleda case of Javanese ethnicity to be documented,
and the unique mutation has not previously been reported. The finding supports the notion
that despite the rarity, SLURP1 mutation causing mal de Meleda is ubiquitous.
Introduction
Mal de Meleda (OMIM# 248300; keratosis palmoplantaris trans-
grediens of Siemens) is an autosomal recessive genodermatoses
characterized clinically by erythema and hyperkeratosis of the
palms and soles with sharp demarcation that progress with age
(progrediens) and extend to the dorsal aspects of the hands and
feet (transgrediens).1,2 The disease was first recognized by Luca
Stulli, a Dubrovnik’s state physician, in 1826 on the Adriatic island
of Meleda.3 The Mljet disease or mal de Meleda is named after
one of the Croatian islands, and it entered the records of world lit-
erature under this name in 1897, thanks to the physicians
Hovorka and Ehlers, and has retained this name up until the
present.4
Mal de Meleda has an onset in early infancy and a preva-
lence of one in 100,000 in the general population.5 The
lesions might be associated with painful fissures, macerations,
hyperhydrosis, perioral erythema, prominent knuckle pads, nail
abnormalities, malodourous because of microbial superinfec-
tion, pseudoainhum, and brachydactyly, as well as congenital
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cataracts.6–11 Histologically, the lesions show hyperkeratosis
and acanthosis without epidermolysis in the epidermis,
accompanied by perivascular lymphocytic infiltrate in the
dermis.9,12
The mal de Meleda gene has been mapped to chromosome
8q24.3,1 with mutations in ARS (component B)-81/s gene (LY6LS),
also known as SLURP1, encoding secreted Ly-6/uPAR related
protein 1 (SLURP1).1,13 Cases of mal de Meleda with SLURP1
mutations have been reported in Algerian,1 Bedouin,14 Chinese,15
Croatian,1 Dutch,16,17 German,14,16,18 Indian,19 Indonesian,20
Italian,21 Japanese,6,22 Korean,23 Kurdish,2 Libyan,24 Pakistani,25
Palestinian,14 Scottish,18 Swedish,26 Taiwanese27,28 Tuni-
sian,18,21,29 and Turkish descents.14,30–33
To date no cases has been reported from a Javanese family,
though the mutation has been reported in Indonesian woman
who live in Australia.20 In this report, we describe a familial case
of mal de Meleda with a unique mutation in SLURP1 gene in a
Javanese family, which substantiates that mal de Meleda
because of SLURP1 mutation is ubiquitous and Javanese
ethnicity is not spared from the occurrence.
Patients and methods
The study conformed to the ethical guidelines of the Medical
and Health Research Ethics Committee (MHREC) Faculty of
Medicine Universitas Gadjah Mada, Yogyakarta, Indonesia.
Patients and all family members provided consent prior to the




A 22-year-old Javanese male (II.1) presented with sharply
demarcated hyperkeratotic plaques on the palms and soles
since the first 5 months of life that extended onto the upper
arms and legs. He also complained of malodor on the palms
and soles as well as athlete’s foot that recurred intermittently,
especially during hot season. Physical examination revealed
transgressive hyperkeratosis and erythema of the palms
(Fig. 1a) and soles (Fig. 2a), extending to the upper arms
Figure 1 Sharply demarcated hyperkeratosis and erythema of the palms extending to the dorsum of the hands symmetrically (a) Patient 1;
(b) Patient 2; (c) Patient 3
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(Fig. 3a) and legs (Fig. 4a) symmetrically, 20-nails dystrophy as
well as perioral and nose erythema. He experienced seizures at
1 year old. He has two younger brothers and a sister, two of
whom have the same symptoms (II.3, II.4) (Fig. 5).
Patient 2
A 14-year-old girl (II.3) presented with extensive palmoplantar
hyperkeratosis which extended onto the dorsal surfaces of the
hands and feet since her first 3 months of life. Physical
examination revealed hyperkeratosis and erythema of the palms
(Fig. 1b) and soles (Fig. 2b) with transgrediens, extending to
the lower arms (Fig. 3b) and lower legs (Fig. 4b), as well as
nail dystrophy. Similar with her older brother, she experienced
seizures at the age of 2 years.
Patient 3
A 12-year-old boy (II.4) presented diffuse erythema and
hyperkeratosis of the hands (Fig. 1c) and feet (Fig. 2c) that
appeared during the first 2 weeks of life and progressively
extended to the dorsal aspect of the lower arms (Fig. 3c) and
Figure 2 Sharply demarcated
hyperkeratosis and erythema of the soles
extending to the dorsal aspects of the feet
symmetrically (a) Patient 1; (b) Patient 2; (c)
Patient 3
Figure 3 The lesion extending to the upper
arms (a) Patient 1, symmetrically; (b) Patient
2, lower arms; (c) Patient 3, lower arms
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thighs with an area of normal skin on the lower legs
symmetrically (Fig. 4c).
All the patients experienced hyperhidrosis localized on
the palms and soles. We performed histopathology of all
patients.
PCR and sequencing for the SLURP-1 mutation
screening
Genomic DNA was isolated from blood samples by E.Z.N.A
Blood DNA Kit (Omega Bio-tek, Norcross, Georgia, USA)
according to the manufacturer’s protocol. Polymerase chain
reaction (PCR) amplification of DNA was performed with
specific sets of primers for all three exons of SLURP1 gene
that includes part of the 50UTR in exon 1, the flanking
introns, and the 30UTR in exon 3. The amplicons were
purified using Qiagen Purification Kit (Qiagen GmbH, Hilden,
Germany). The purified products were directly sequenced
using the Big Dye Terminator Sequencing Kit (Version 3.0
Cycle Sequencing Kit) and analyzed on the ABI 3700 DNA
sequencing system (PE Applied Biosystems, Foster City, CA).
Sequence comparisons and analysis were performed using
Basic Local Alignment Search Tool (BLAST) from the
National Centre for Biotechnology Information (NCBI) with
SLURP1 GenBank accession number NG_011494 (NCBI) or
606119 (MIM) as reference.
To validate the mutation, various databases of genetic
variation in SLURP1 were screened for the same
mutation found in the affected members of the family in this
study.
PCR and subcloning to characterize the nucleotide
changes
DNA amplification was done to amplify exon 3 of SLURP1
using a pair of specific primers located in intron 2 and the
30UTR in exon 3. PCRs was performed under optimized
conditions using GoTaq DNA Polymerase (Promega Corp,
Madison, WI, USA) in a DNA Thermal Cycler 480 (Perkin-
Elmer, Branchbura, NJ, USA). The amplicons were then cloned
into TOPO XL PCR cloning kit (Invitrogen, Carlsbad, CA,
USA) following the protocol provided by the manufacturer. A
number of clones were picked randomly, and their sequences
were characterized by sequencing using primers to reveal the
sequence of each SLURP1 allele in the region that contained
exon 3 and its partial flanking introns. Sequencing was
performed using a DNA Sequencing Kit with BigDye
Terminators ABI 373 automated DNA Sequencer (Applied
Biosystems). The primers used for PCR and sequencing are
available upon request.
Figure 4 The lesion extending to upper
legs (a) Patient 1; (b) Patient 2
symmetrically; (c) Patient 3 to thighs with
area of normal skin on the lower legs
Figure 5 Pedigree of the family
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Results
Clinical data
Physical examination of all affected individuals showed classical
findings of mal de Meleda, i.e. transgressive keratoderma from
the palms and soles progressively extending to the dorsa of the
hands and feet, erythema surrounding the hyperkeratotic
lesions, in a “glove-and-socks” distribution. Nail dystrophy with
subungual hyperkeratosis were observed in all patients. The
histopathologic study of all patients showed marked hyperker-
atosis, acanthosis, and normogranulosis, without epidermolysis
in the epidermis, accompanied by perivascular lymphocytic infil-
trate in the dermis.
The parents did not show any skin symptoms (I.2 and I.3),
were otherwise healthy, and were not consanguineous, and
there were no other family members affected with the same
disease.
Mutation detection and confirmation
PCR amplification of three SLURP1 exons for patients’ DNA
sample yielded amplicons of similar sizes as their unaffected
family members as well as healthy controls. Direct sequencing
of the amplicons showed that all three affected children (II.1,
II.2, and II.4) carry homozygous small three nucleotides deletion
in exon 3, i.e. c.271-273TCTdel or p.Ser91del (Fig. 6a). Both
parents (I.2 and I.3) and one of the father’s siblings (I.1) carry
heterozygous c.271-273TCTdel (Fig. 6c) that was verified by
subcloning. The other father’s sibling (I.2), the mother’s sister
(I.4), and a healthy control matched the ethnicity of the family
showed normal sequence of the entire SLURP1 (Fig. 6b).
Discussion
Mal de Meleda was initially known as a unique form of palmo-
plantar keratoderma found among populations on the Croatian
isle of Mljet with the first to be documented in the 19th century.4
The genetic basis responsible for mal de Meleda, i.e. muta-
tions in SLURP1, was identified by Fischer et al. in 2001.1 To
date, mal de Meleda has been found to affect 19 ethnic popula-
tions, spreading in 21 countries, and associated with at least 20
mutations in SLURP1 (Tables 1 and 2). Majority of the cases
are homozygous mutations with very few patients carrying com-
pound heterozygous mutation. This in accordance with the rarity
of the disease indicating the spread of the disease is still clus-
tered within founder mutations.
Here, we report cases of mal de Meleda in a family of six
with three affected children. All three showed classical symp-
toms of transgrediens and progrediens keratoderma starting
from the palms and soles.
The novel mutation reported here added up the list of the
SLURP1 mutation known to yield mal de Meleda to be at least
20. The most recurrent mutation is c.82delT (p.Cys28fs32X)
that has arisen in 23 kindred from six ethnic groups in six coun-
tries surrounding the Mediterranean Sea. The second most
recurrent mutation is c.43T>C (p.Trp15Arg) that occurred in 17
kindred from four ethnic groups in four European countries.
c.256G>A (p.Gly86Arg) is third in the number of kindred
affected, nine, whereby two being large kindred, but most pro-
lific to be found in six ethnic groups spreading in seven coun-
tries from the USA and middle east to the far east and Australia
(Table 2).
The c.271-273TCTdel (p.Ser91del) was identified in a family
of Javanese ethnicity from a certain area in Central Java with
no knowledge of their consanguinity status. This is the first
Figure 6 Deletion of c.271-273TCT of SLURP1 in homozygous
form (a) was identified in all affected patients. The same mutation in
heterozygous form (c) was identified in both parents and one of the
father’s brother. Healthy controls and the rest of the patients’ family
members tested showed normal sequence of SLURP1 (b)
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report of mal de Meleda in a certain Javanese family. Recently
Taylor et al.20 reported mal de Meleda case with c.256G>A
(p.Gly86Arg) in an Indonesian family that lives in Australia.
Although it was mentioned that both parents of the patients
lived in Jakarta, their ethnicity was not clear. There are more
than 300 ethnic groups in Indonesia,34 whereby 95% of those
are of native Indonesian ancestry.35 Although most of mal de
Meleda cases come from consanguineous families, the two
Indonesian mal de Meleda families both are not known to be
consanguineous. The fact that the patients from both families
carry homozygous mutations highlights the presence of the
mutations’ carriers in their respective communities.
The rarity of the case whereby majority of patients carry
homozygous mutations indicates that the spreading of mal de
Meleda still limited within each founder mutation and de-novo
mutation is rare.
In conclusion, this report highlights the ubiquitous occurrence
of mal de Meleda. Javanese, the biggest ethnic group in
Indonesia, is not spared from this genetic disease. The severity
and debilitating symptoms of the disease warrants genetic
counseling especially for members from families and extended
families with affected individuals.
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Table 1 The list of ethnic groups and SLURP1 mutations that have been identified to be associated with mal de Meleda
Patient’s ethnics Patient’s location Mutation Allele No of kind-red Reference
Algerian Algeria c.82delT (p.Cys28fs32X) Homozygous 9 1
c.178+1G>A Homozygous 3
Bedouin UEA c.1A>C (p.Met1Leu) Homozygous 1 14
Chinese PRC c.256G>A (p.Gly86Arg) Homozygous 2 15
Taiwan c.256G>A (p.Gly86Arg) Homozygous 2 27,28
Croatian Croatia c.82delT (p.Cys28fs32X) Homozygous 4 1
c.286C>T (p.Arg96X) Homozygous 3
Dutch Netherlands c.43T>C (p.Trp15Arg) Homozygous 3 16
c.43T>C (p.Trp15Arg) Heterozygous 1 17
c.212G>C (p.Arg71Pro)
German Germany c.43T>C (p.Trp15Arg) Homozygous 3 14,16,18
Indian India c.58+5G>T Homozygous 1 19
Indonesian (Ethnic unspecified) Australia c.256G>A (p.Gly86Arg) Homozygous 1 20
Italian Italy c.82delT (p.Cys28fs32X) Not known Not known 21
Japanese Japan c.58+1G>C Homozygous 1 6
c.211C>T (p.Arg71>Cys) Homozygous 1 22
Javanese Indonesia c.271-273TCTdel (p.Ser91del) Homozygous 1 This report
Korean Korea c.256G>A (p.Gly86Arg) Heterozygous 1 23
c.286C>T (p.Arg96X)
Kurdish Turkey c.82delT (p.Cys28fs32X) Homozygous 1 2
Libyan Libya c.256G>A (p.Gly86Arg) Homozygous 1 24
Pakistani USA c.58+1G>A Homozygous 1 big 25
c.256G>A (p.Gly86Arg) Homozygous 1 big
c.286C>T (p.Arg96X) Homozygous 1 big
Scottish Scotland c.43T>C (p.Trp15Arg) Heterozygous 1 18
c.82delT (p.Cys28fs32X)
Swedish Sweden c.43T>C (p.Trp15Arg) Homozygous 8 26
c.43T>C (p.Trp15Arg) Heterozygous 1
c.280T>A (p.Cys94Ser)
Tunisian Tunisia c.82delT (p.Cys28fs32X) Homozygous 7 18,21,29
c.229T>C (p.Cys77Ala) Homozygous 2 29
c.296G>A (p.Cys99Tyr) Homozygous 4 (1 being a big kindred) 18,21,29
Turkish Turkey c.129C>A (p.C43X) Homozygous 1 30
c.256G>C (p.Gly86Arg) Homozygous 1 14
c.286C>T (p.Arg96X) Homozygous 1 2
c.293T>C (p.Leu98Pro) Homozygous 1 32
Austria c.244C>T (p.Pro82Ser) Homozygous 1 33
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